InsidersTradesSigma
Track the ブライトパス・バイオ share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the supervision of EDINET (Japan FSA). Market capitalisation: €6.5bn. The latest transaction was filed on 19 February 2026 (Holding update). Among the most active insiders: Phillip Securities Japan,Ltd.. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
BrightPath Bio es una empresa centrada en el desarrollo de terapias innovadoras en biotecnología. Cotiza en el mercado XTKS.